Please login to the form below

Not currently logged in

Former Genzyme group vice president joins Vedanta Biosciences

Dr Bruce Roberts takes up the role of chief scientific officer

Vedanta Biosciences Dr Bruce RobertsVedanta Biosciences has appointed Dr Bruce Roberts as chief scientific officer at its new Cambridge, Massachusetts, site.

Dr Roberts will take responsibility for the company's research and development division, bringing over 30 years of experience in biotechnology and pharmaceutical drug discovery and development to the firm.

He first joined Sanofi Genzyme as general manager of its Cambridge, UK-based therapeutic antibody centre in 2004 before being promoted to group vice president and head of neuro-immunology and immune-mediated disease research in 2006.

In this role, Dr Roberts directed multiple clinical trials for the treatment of autoimmunity, cancer and multiple sclerosis as well as managing research efforts into a number of now-approved products.

Vedanta's chief executive officer Dr Bernat Olle said: “Bruce brings decades of drug development experience across a broad range of novel biologic drug modalities and a proven track record of driving the discovery and development of multiple approved drugs in immunology.

“His experience and leadership in pioneering new drug modalities will be invaluable as we advance our pipeline of microbiome-modulating therapies.”

Dr Roberts said: “Microbiome modulation is among the most exciting and rapidly evolving fields in science and it has tremendous potential to change the way medicine is practiced.

“I am excited to join one of the leading teams in this field and I look forward to driving Vedanta's technology platform and pipeline forward.”

29th March 2016

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....